- Fast Track designation indicates LBS-007s potential in filling the unmet medical need of acute leukemia
- LBS-007 is the Companys investigational medicinal product for the treatment of … [+4985 chars]
TAIPEI CITY, Taiwan, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Lin BioScience (6696. Taiwan OTC), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting acute leukemia that have significant unmet medical